News Focus
News Focus
icon url

pinhigh

04/13/26 4:25 PM

#352300 RE: normal investor #352298

Maybe Haleon...Maybe not! Regardless...Electrome is busy exposing the the value in Biel's pain relief tech! This is precisely what Biel needs right now! Having trouble understanding why anyone would want to fabricate a partnership between Biel and Haleon. Go Biel!
icon url

srinsocal

04/14/26 11:04 AM

#352332 RE: normal investor #352298

Ok, I did a deep dig, found dozens and dozens of 'adhocnews.de' articles on Voltaren

IMO, Haleon is paying adhocnews to promote Voltaren. Haleon probably writes the articles, adhocnews slaps one of their phony author names on it and publishes. A multi-billion dollar company like Haleon is not going to allow anyone to publish false information about their cash cow Voltaren.

I only found two other references to Voltaren R&D in the list below. Neither mentioned ActiPatch. If my theory is correct Haleon wrote the original mention of a 'Voltaren ActiPatch' that Hawk found dated 3/15/2026.

Here is a small sample of the articles that came up on a "CH-Lizenz Voltaren" google search:

2/3/2026 Voltaren in the US: What Swiss roots mean for your pain relief now
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-in-the-us-what-swiss-roots-mean-for-your-pain-relief-now/68625804

2/14/2026 Voltaren (CH-Lizenz) Review: The Pain-Relief Gel Everyone in Switzerland Is Reaching For
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-ch-lizenz-review-the-pain-relief-gel-everyone-in-switzerland/68581311

2/15/2026 Voltaren (CH-Lizenz) Review: Can This Swiss-Approved Gel Really Turn Down Your Pain in Minutes?
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-ch-lizenz-review-can-this-swiss-approved-gel-really-turn-down/68583727

2/17/2026 Voltaren (CH license): What is really behind the pain gel hype
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-ch-lizenz-was-hinter-dem-schmerzgel-hype-wirklich-steckt/68586655

2/18/2026 Voltaren Gel in the US: What Novartis’s Pain Reliever Really Delivers
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-gel-in-the-us-what-novartis-s-pain-reliever-really-delivers/68590157

2/18/2026 Voltaren Gel in the U.S.: What Actually Works for Pain Relief Now
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-gel-in-the-u-s-what-actually-works-for-pain-relief-now/68590395

2/26/2026 Voltaren Gel in the U.S.: What Actually Works for Pain Relief Now
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-gel-in-the-u-s-what-actually-works-for-pain-relief-now/68590395

2/26/2026 Voltaren gel: Why this Swiss painkiller is quietly winning in the US
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-gel-why-this-swiss-painkiller-is-quietly-winning-in-the-us/68615811

3/3/2026 Voltaren in Germany: What the CH license really does for your pain therapy
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-in-deutschland-was-die-ch-lizenz-fuer-deine-schmerztherapie/68632028

3/7/2026 Voltaren in Germany: What the CH license means for your pain
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-in-deutschland-was-die-ch-lizenz-fuer-deine-schmerzen-bedeutet/68645166

3/14/2026 Voltaren (CH-Lizenz): Why This Painkiller Still Dominates 2026
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-ch-lizenz-why-this-painkiller-still-dominates-2026/68675362

3/14/2026 Voltaren (CH-Lizenz): Haleon's Powerhouse Brand Drives Swiss Market Resilience Amid 2025 Growth
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-ch-lizenz-haleon-s-powerhouse-brand-drives-swiss-market/68680277

3/15/2026 Voltaren Gel: Haleon's Powerhouse in Swiss Pain Relief Market Stability
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-gel-haleon-s-powerhouse-in-swiss-pain-relief-market-stability/68683429

3/16/2026 Voltaren Pain Relief Gel Faces New Supply Challenges in Swiss Market Amid Haleon Ownership Shift
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-pain-relief-gel-faces-new-supply-challenges-in-swiss-market-amid/68850764

3/19/2026 Voltaren Pain Relief Gel Faces New Supply Challenges in Swiss Market Amid Haleon Ownership Shift
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-pain-relief-gel-faces-new-supply-challenges-in-swiss-market-amid/68850764

3/22/2026 Voltaren Wärmepflaster: Haleon's Heat Patch Drives 4-6% Sales Growth in DACH Pain Relief Market
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-waermepflaster-haleon-s-heat-patch-drives-4-6-percent-sales/68959159
"Innovation Pipeline and Future Outlook
Haleon eyes an extra-strong 12-hour variant, currently in prototype testing. Allergen tweaks and moisture tech enhance it further, targeting 2027 launch
Smart sensor research promises personalized therapy, potentially revolutionizing home pain management. Integration with wearables could track usage and efficacy. DACH expansion plans include targeted campaigns for chronic pain sufferers. Partnerships with sports federations boost visibility among athletes.
Sustainability efforts incorporate eco-friendly materials, aligning with regional green preferences. Recyclable packaging appeals to conscious consumers."


3/23/2026 Voltaren Wärmepflaster Drives Haleon's 4-6% Sales Growth in DACH Pain Relief Market
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-waermepflaster-drives-haleon-s-4-6-percent-sales-growth-in-dach/68967245 "Pipeline includes smart variants with usage sensors, eyeing digital health integration. Wearable compatibility could track pain patterns."

3/24/2026 Voltaren Topical Pain Relief: Comprehensive Guide to Switzerland's Licensed Painkiller Leader
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-topical-pain-relief-comprehensive-guide-to-switzerland-s/68978345

3/29/2026 Voltaren Pain Relief Gel: Global Market Leader Faces Evolving Ownership and Regional Licensing Chall
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-pain-relief-gel-global-market-leader-faces-evolving-ownership/69019184

3/29/2026 Voltaren Pain Relief Gel: Global Market Leader Faces Evolving Ownership and Regional Licensing Chall
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-pain-relief-gel-global-market-leader-faces-evolving-ownership/69019184

4/12/2026 Voltaren (CH license): Why the market leader in DACH is now becoming more strategically important
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-ch-lizenz-warum-der-marktfuehrer-in-dach-jetzt-strategisch/69132325

4/13/2026 Voltaren (CH-Lizenz): Between stable demand and generics, now it gets interesting
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-ch-lizenz-entre-demanda-estable-y-genericos-ahora-se-pone/69138629

4/13/2026 Voltaren Topical Pain Relief: Haleon's Flagship Product Driving Steady Consumer Staples Demand in No
https://www.ad-hoc-news.de/boerse/news/ueberblick/voltaren-topical-pain-relief-haleon-s-flagship-product-driving-steady/69076412
icon url

puffadder

04/14/26 11:28 AM

#352333 RE: normal investor #352298

Last BIEL PR 10/25/25?